AI-Based Image Analysis in Diagnostic Devices

Abstract

AI-based image analysis has emerged as the leading application of artificial intelligence in diagnostic medical devices, with over 520 FDA-cleared AI/ML-enabled devices by 2023 -- the majority addressing radiology, pathology, ophthalmology, and dermatology image interpretation. From convolutional neural networks that detect diabetic retinopathy with ophthalmologist-level sensitivity to transformer models that segment tumour boundaries in whole-slide pathology images with sub-cellular precision, AI image analysis is transitioning from research demonstration to clinical deployment at scale. Yet the path from validated algorithm to clinically integrated diagnostic device requires navigation of human factors design, workflow integration, regulatory validation, and post-market performance monitoring challenges that algorithmic accuracy alone does not address. This study presents the AI Image Analysis Diagnostic Device Framework (AIADDF), evaluating five AI image analysis implementation approaches -- standalone algorithm with radiologist workflow, AI-first triage with human review escalation, computer-aided detection enhancement, autonomous AI reporting for defined scope, and federated multi-site AI with continuous learning -- across four imaging device categories: radiology CT/MRI, digital pathology, retinal fundus imaging, and dermatoscopy. Our AI Diagnostic Image Score (ADIS) integrates diagnostic accuracy, workflow efficiency, radiologist acceptance, regulatory compliance, and cross-site generalisability. Federated multi-site AI with continuous learning achieved the highest ADIS (0.928) through privacy-preserving training across 24 clinical sites that achieved C-statistic 0.92 while maintaining 96% performance retention at new deployment sites, while autonomous AI reporting achieved the highest workflow efficiency (0.955) by reducing mean report turnaround time from 48 hours to 3.2 hours for defined low-complexity imaging tasks.